In this article, we discuss 5 stocks under $10 in Cathie Wood’s latest portfolio. If you want to read about some more stocks in the Wood portfolio, go directly to Cathie Wood’s Latest Portfolio: 10 Stocks Under $10.
5. Organovo Holdings, Inc. (NASDAQ:ONVO)
Number of Hedge Fund Holders: 4
Share Price as of May 16: $2.55
Organovo Holdings, Inc. (NASDAQ:ONVO) is a biotech firm based in California. Latest 13F filings show that ARK owned 306,108 shares of Organovo Holdings, Inc. (NASDAQ:ONVO) at the end of March 2022, worth $1.1 million. The fund decreased its stake in the company by 8% in the first quarter of 2022 compared to filings for the fourth quarter of 2021. The firm has featured in the ARK portfolio since the third quarter of 2020. ARK has been dumping the stock gradually every quarter since then.
On February 23, Organovo Holdings, Inc. (NASDAQ:ONVO) announced that it had reached an agreement with BICO, a biotech firm, to use the technology of the latter in the foundational patent portfolio of 3D bioprinting.
Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Renaissance Technologies is a leading shareholder in Organovo Holdings, Inc. (NASDAQ:ONVO), with 158,801 shares worth more than $1.1 million.
4. IronSource Ltd. (NYSE:IS)
Number of Hedge Fund Holders: 24
Share Price as of May 16: $2.80
IronSource Ltd. (NYSE:IS) owns and runs a business platform for app developers and telecom operators. Latest 13F filings show that ARK owned over 388,040 shares of IronSource Ltd. (NYSE:IS) at the end of March 2022, worth $1.8 million. In earnings results for the first quarter of 2022, IronSource beat market expectations on revenue by over $6 million. Tomer Bar-Zeev, the CEO of the firm, said during the earnings call that the company was one of the few software entities that grew revenue by 55%, while keeping margins at over 30% in the past months.
On May 13, Needham analyst Bernie McTernan maintained a Buy rating on IronSource Ltd. (NYSE:IS) stock and lowered the price target to $6 from $10, noting the weakened guidance of the firm but affirming that it was a “leading game-tech operator in in-app gaming ads”.
At the end of the fourth quarter of 2021, 24 hedge funds in the database of Insider Monkey held stakes worth $457 million in IronSource Ltd. (NYSE:IS), compared to 29 in the preceding quarter worth $726 million.
3. Allot Ltd. (NASDAQ:ALLT)
Number of Hedge Fund Holders: 14
Share Price as of May 16: $5.27
Allot Ltd. (NASDAQ:ALLT) provides network intelligence and security solutions. Regulatory filings reveal that ARK owned 252,341 shares of Allot Ltd. (NASDAQ:ALLT) at the end of the first quarter of 2022, worth $2 million. The fund increased its stake in the firm by 23% in the first three months of 2022 compared to filings for the fourth quarter of 2021. The firm has been a consistent feature in the ARK portfolio since the second quarter of 2019. Over the last three quarters, ARK has been loading up on the stock.
In mid-February, Lake Street analyst Eric Martinuzzi maintained a Buy rating on Allot Ltd. (NASDAQ:ALLT) stock but lowered the price target to $13 from $16, lowering the profit and revenue forecasts for the firm in 2022 as well.
Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Renaissance Technologies is a leading shareholder in Allot Ltd. (NASDAQ:ALLT), with 1.2 million shares worth more than $10 million.
2. RedHill Biopharma Ltd. (NASDAQ:RDHL)
Number of Hedge Fund Holders: 4
Share Price as of May 16: $1.02
RedHill Biopharma Ltd. (NASDAQ:RDHL) is a biopharma firm that focuses on the development of medicines for gastrointestinal and infectious diseases. Securities filings show that ARK owned 861,798 shares of RedHill Biopharma Ltd. (NASDAQ:RDHL) at the end of March 2022, worth $2.1 million. The company is a new addition to the portfolio compared to filings for the fourth quarter of 2021. However, the firm has featured in the ARK portfolio, with a minor exception in late 2021, since early 2018.
On March 15, RedHill Biopharma Ltd. (NASDAQ:RDHL) announced that it had inked an exclusive license agreement with Kukbo, a Seoul-based conglomerate, for the commercialization of oral opaganib, a drug for the treatment of COVID-19.
At the end of the fourth quarter of 2021, 4 hedge funds in the database of Insider Monkey held stakes worth $965,000 in RedHill Biopharma Ltd. (NASDAQ:RDHL), up from 3 in the preceding quarter worth $443,000.
1. Taboola.com Ltd. (NASDAQ:TBLA)
Number of Hedge Fund Holders: 25
Share Price as of May 16: $3.35
Taboola.com Ltd. (NASDAQ:TBLA) owns and runs an artificial intelligence-based algorithmic engine platform. Latest data shows that ARK owned 423,119 shares of Taboola.com Ltd. (NASDAQ:TBLA) at the end of the first quarter of 2022, worth $2.1 million. The firm is a new addition to the portfolio compared to fourth quarter filings. Taboola recently posted earnings for the first quarter of 2022, beating market expectations on earnings per share by $0.025 and reporting a 17% year-on-year increase in revenue.
On March 31, Susquehanna analyst Shyam Patil maintained a Positive rating on Taboola.com Ltd. (NASDAQ:TBLA) stock with a price target of $10, noting that new engagement initiatives of the firm would provide fuel for growth in the coming months.
Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Renaissance Technologies is a leading shareholder in Taboola.com Ltd. (NASDAQ:TBLA), with 423,119 shares worth more than $2.1 million.
You can also take a peek at 10 Stocks Reddit’s WallStreetBets is Buying in July 2021 and Top Robinhood Stocks Popular on Reddit.
